secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001683168-21-003222
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech reports preliminary FY2021 net loss of $3.6M, cash $2.2M
---------------------------------------------------------------------------

- Net loss for FY2021 was approx. $3.6M ($2.45 loss per share) vs. $3.8M ($4.23 loss per share) in FY2020.
- Cash on hand as of April 30, 2021 was approx. $2.2M.
- Results are preliminary and unaudited, subject to completion of financial closing procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316821003222/0001683168-21-003222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316821003222/pharma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-003222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer